AQST vs PFE · rev $28.3M vs P/E 20, rev $15.03B
Aquestive Therapeutics Inc (AQST) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
AQST currently screens at market cap $493.0M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the AQST and PFE stock pages for the full models.
Not investment advice.